Results 111 to 120 of about 302,854 (293)

Prescription of antihypertensive agents in the treatment of hypertension in diabetic nephropathy patients on hemodialysis

, 2021
Kalpana Bharani, Rubina Vohra, Rajesh Bharani, Chhaya Goyal, Pooja Reddy   +4 more
openalex   +2 more sources

Blood pressure targets in the elderly [PDF]

, 2018
No abstract ...
Currie, Gemma, Delles, Christian
core   +1 more source

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali, Stephan van Erp, Cornelis Kramers, Cornelis J. Tack, Bastiaan E. de Galan   +4 more
wiley   +1 more source

Author response for "Genetic risk of hyperuricemia in hypertensive patients associated with antihypertensive drug therapy: a longitudinal study"

, 2021
Yu Chen, Yunyun Yang, Yixuan Zhong, Jian Li, Tao Kong, Shuyuan Zhang, Shujun Yang, Cunjin Wu, Bing Cui, Li Fu, Rutai Hui, Weili Zhang   +11 more
openalex   +1 more source

Case-control study of stroke and the quality of hypertension control in north west England [PDF]

, 1997
Objective: To examine the risk of stroke in relation to quality of hypertension control in routine general practice across an entire health district. Design: Population based matched case-control study.
Cruickshank, K, Du, X, Holmes, S, McNamee, R, Roberts, N, Saraee, MH, Sourbutts, J, Summers, A, Walton, E   +8 more
core   +2 more sources

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Motivational Interviewing Impact on Cardiovascular Disease [PDF]

, 2020
: Harm reduction in cardiovascular disease is a significant problem worldwide. Providers, families, and healthcare agencies are feeling the burdens imparted by these diseases.

core  

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki, Tetsu Watanabe, Mari Shimizu, Shingo Tachibana, Junya Sato, Yuta Kobayashi, Harutoshi Tamura, Shigehiko Kato, Satoshi Nishiyama, Hiroki Takahashi, Takanori Arimoto, Masafumi Watanabe   +11 more
wiley   +1 more source

Development of nifedipine isosteres: an integrated approach to the design, synthesis, and biological assessment of calcium channel blockers

Frontiers in Chemistry
This study reports the synthesis of a series of calcium channel blockers via Biginelli’s reaction. The core dihydropyridine (DHP) scaffold, an isostere of nifedipine, was synthesized using three aldehydes incorporated with trifluoromethyl (–CF3 ...
Yasser M. Zohny, Yasser M. Zohny, Samir M. Awad, Samir M. Awad, Omar Alsaidan, Maha A. Rabie, Maha A. Rabie   +6 more
doaj   +1 more source

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

ESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié, Richard Isnard, Françoise Pousset, Clémence Grave, Jacques Blacher, Amélie Gabet   +5 more
wiley   +1 more source